KMDA
KMDA
NASDAQ · Biotechnology

Kamada Ltd

$8.76
+0.02 (+0.23%)
As of Sep 22, 2:55 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +231.3% upside
Low Target $25.25
Average Target $29.02
High Target $47.24
Current Price $8.76
Current
$8.76
Target
$29.02
$25.25 $29.02 avg $47.24
Scenario Analysis
Bear Case
$25.25
188.2%
Low target
Base Case
$29.02
+231.3%
Avg target
Bull Case
$47.24
+439.3%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$9.35
-6.3% from high
52-Week Low
$6.50
+34.8% from low
Target vs 52W High
$29.02
+210.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%